Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2)

被引:1
|
作者
Youil, R
Kiselava, I
Kwan, WS
Szymkowiak, C
Toner, TJ
Su, Q
Klimov, A
Rudenko, L
Shaw, AR
机构
[1] Merck & Co Inc, Dept Virus & Cell Biol, W Point, PA 19486 USA
[2] Russian Acad Med Sci, Inst Expt Med, St Petersburg 197376, Russia
[3] Ctr Dis Control & Prevent, Influenza Branch, Atlanta, GA 30333 USA
关键词
cold-adaptive influenza vaccine; influenza A virus; vero cells;
D O I
10.1016/j.virusres.2004.01.026
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
For the past three decades the cold-adapted (ca) and temperature sensitive (ts) master donor strain, A/Leningrad/134/17/57 (H2N2) has been successfully used as the basis for the live attenuated reassortant influenza A vaccine. This donor strain was developed from A/Leningrad/134/57 (H2N2) wild-type (wt) virus following 17 passages in eggs at 25 degreesC. Our detailed investigation has revealed that the A/Leningrad/134/17/57 (Len/17) master donor stock is a mixed population comprised of numerous variants of the ca/ts Len/17 influenza virus. We have identified these variants to exhibit a broad range in their temperature sensitive phenotype when assayed on Madin-Darby canine kidney (MDCK) cells at 37 degreesC. A selection of these variant clones has been fully characterized by sequencing in order to understand the variability in the ts phenotype. This study has also addressed the feasibility of using cell culture technology for the propagation and subsequent manufacturing of the cold-adapted influenza vaccine (CAIV), particularly with respect to retaining the defined mutations that contribute toward the ca/ts phenotype. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 41 条